Recombinant Human HTRA4 Protein，His

HTRA4, a member of the high-temperature requirement A (HTRA) family of serine proteases, has gained significant attention in recent years due to its critical roles in various physiological processes and diseases. Originally identified in human tissues, HTRA4 is primarily expressed in the placenta and has been implicated in placental development and function. Research indicates that HTRA4 plays a crucial role in the modulation of cell migration, apoptosis, and extracellular matrix remodeling, making it essential for proper embryonic development. Moreover, studies have shown that altered expression levels of HTRA4 are associated with several pathological conditions, including cancer, cardiovascular diseases, and neurodegenerative disorders. Its proteolytic activity and regulatory functions suggest that HTRA4 may contribute to tumor progression by influencing the tumor microenvironment and mediating stress responses. Consequently, understanding the molecular mechanisms underlying HTRA4's activity is critical for exploring its potential as a therapeutic target. Research efforts are currently focused on characterizing the biochemical properties of HTRA4, including its substrate specificity and regulation, which may lead to insights into its roles in health and disease. Additionally, the development of recombinant HTRA4 proteins could facilitate studies on its functions and interactions, paving the way for novel therapeutic strategies that harness its proteolytic capabilities. Overall, the study of HTRA4 represents a burgeoning field that merges basic biology with clinical relevance, holding promise for advancements in disease treatment and understanding of developmental biology.